Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study

BACKGROUND: Negative symptoms and diminished cognitive ability are also considered as core features of schizophrenia. There are many studies in which negative symptoms and cognitive impairments are individually treated with atypical antipsychotic in comparison with either a placebo or a typical anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Subodh, Chaudhury, Suprakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261210/
https://www.ncbi.nlm.nih.gov/pubmed/25535442
http://dx.doi.org/10.4103/0972-6748.144953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261210/
https://www.ncbi.nlm.nih.gov/pubmed/25535442
http://dx.doi.org/10.4103/0972-6748.144953

Ejemplares similares